Gastrointestinal tumours, non-colorectal
Gastrointestinal tumours, non-colorectal: Invited Discussant 620PD, 621PD, 622PD and 623PD
Date
11 Sep 2017Session
Gastrointestinal tumours, non-colorectalPresenters
Stefano CascinuAuthors
S. CascinuAuthor affiliations
- Department Of Oncology , AOU Ospedali Riuniti Ancona Università Politecnica delle Marche, 60126 - Ancona/IT
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
2205 - A phase III trial of muparfostat (PI-88) as adjuvant therapy in patients with hepatitis virus related hepatocellular carcinoma (HV-HCC) after resection
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
1091 - A phase I and randomized phase II trial to evaluate the efficacy and safety of nab-paclitaxel (nab-P) in combination with gemcitabine (G) for the treatment of patients with ECOG 2 advanced pancreatic cancer (PDAC).
Presenter: Manuel Hidalgo
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
2743 - A Phase 2b of eryaspase in combination with gemcitabine or FOLFOX as second-line therapy in patients with metastatic pancreatic adenocarcinoma (NCT02195180)
Presenter: Pascal Hammel
Session: Gastrointestinal tumours, non-colorectal
Resources:
Abstract